Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. N2EW34
9. INTC
10. IMNN

Go back to Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units

Pfizer (PFE), Glaxo (GSK) to Collaborate on PCMM Prototype for OSD

October 29, 2015 8:29 AM EDT

Pfizer (NYSE: PFE) announced a multi-year collaboration with GlaxoSmithKline (NYSE: GSK) on the development of a next-generation equipment design, building upon Pfizers existing portable, continuous, miniature and modular (PCMM) prototype for oral solid dose (OSD) pharmaceutical development and manufacturing.

Pfizers current PCMM prototype is an autonomous and transportable pod that may be quickly shipped from location to location and readily brought... More